Sanofi A/S

CVR: 19064301

Growing 5% p.a.Medium companyWell-established (30 yrs)Breakeven

Secondary names: AVENTIS A/S, RHONE-POULENC RORER A/S, HOECHST MARION ROUSSEL A/S

Active

Sanofi A/S is experiencing a declining trend in revenue and profitability, with 2024 revenue at 452.6 million DKK and a profit of 6.2 million DKK, down from 527.6 million DKK and 3.7 million DKK in 2023. The company’s equity has shown a gradual increase, reaching 53.6 million DKK in 2024, but this is accompanied by a significant drop in profit margins from 21.9 million DKK in 2021 to just 6.2 million DKK in 2024. The declining revenue and profit suggest potential challenges in maintaining its competitive position within the pharmaceutical wholesale industry. Overall, while the equity position is relatively stable, the decreasing profitability raises concerns about future financial health.

AI-generated summary

Overview

Company type: A/S; Aktieselskab
Address: Lyngbyvej 2, 2100 København Ø; KØBENHAVN; 2100 København Ø; Find nearby companies
Founded: 15.1.1996

Details

Industry: Engroshandel med medicinalvarer og sygeplejeartikler; Code: 464610
Employees: 98 employees; 96 FTE; (2018)
Capital: 7.000.000 kr.

Contact

Phone: Log in to see

Purpose

Selskabets formål er at drive handel og produktion af farmaceutiske produkter og alle aktiviteter, der relaterer sig til research, udvikling, produktion, udnyttelse og marketing af bio-farmaceutiske og farmaceutiske produkter, inklusive vacciner, serummer, immummodulatoer og produkter afledt fra bio-teknologi og højteknologi beregnet til humanmedicinske lægemidler.